142 related articles for article (PubMed ID: 38616354)
1. Comparative study of imaging and pathology of primary mucinous adenocarcinoma with different imaging manifestations.
Han J; Gao J; Chen D; Du M; Wu Y; Ma X; Xie M; Han H; Wu C; Xue X
Clin Respir J; 2024 Apr; 18(4):e13750. PubMed ID: 38616354
[TBL] [Abstract][Full Text] [Related]
2. Comparative study of imaging and pathological evaluation of pneumonic mucinous adenocarcinoma.
Han J; Wu C; Wu Y; Deng H; Gao J; Han H; Xue X
Oncol Lett; 2021 Feb; 21(2):125. PubMed ID: 33552246
[TBL] [Abstract][Full Text] [Related]
3. Correlation exploration among CT imaging, pathology and genotype of pulmonary ground-glass opacity.
Cai Y; Chen T; Zhang S; Tan M; Wang J
J Cell Mol Med; 2023 Jul; 27(14):2021-2031. PubMed ID: 37340599
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors for invasive mucinous adenocarcinoma of the lung: systematic review and meta-analysis.
Zhao T; Yi J; Luo D; Liu J; Fan X; Wu Q; Wang W
World J Surg Oncol; 2024 Feb; 22(1):41. PubMed ID: 38303008
[TBL] [Abstract][Full Text] [Related]
5. HRCT features of surgically resected invasive mucinous adenocarcinoma associated with interstitial pneumonia.
Miyamoto A; Kurosaki A; Fujii T; Kishi K; Homma S
Respirology; 2017 May; 22(4):735-743. PubMed ID: 27860028
[TBL] [Abstract][Full Text] [Related]
6. [Relationship between EGFR, ALK Gene Mutation and Imaging
and Pathological Features in Invasive Lung Adenocarcinoma].
Yang H; Liu Z; Wang H; Chen L; Wang J; Wen W; Xu X; Zhu Q
Zhongguo Fei Ai Za Zhi; 2022 Mar; 25(3):147-155. PubMed ID: 35340157
[TBL] [Abstract][Full Text] [Related]
7. Comparative analysis of clinicoradiologic characteristics of lung adenocarcinomas with ALK rearrangements or EGFR mutations.
Zhou JY; Zheng J; Yu ZF; Xiao WB; Zhao J; Sun K; Wang B; Chen X; Jiang LN; Ding W; Zhou JY
Eur Radiol; 2015 May; 25(5):1257-66. PubMed ID: 25577516
[TBL] [Abstract][Full Text] [Related]
8. The clinicopathological significance of ALK rearrangements and KRAS and EGFR mutations in primary pulmonary mucinous adenocarcinoma.
Qu Y; Che N; Zhao D; Zhang C; Su D; Zhou L; Zhang L; Wang C; Zhang H; Wei L
Tumour Biol; 2015 Aug; 36(8):6417-24. PubMed ID: 25813151
[TBL] [Abstract][Full Text] [Related]
9. Napsin-A, TTF-1, EGFR, and ALK Status Determination in Lung Primary and Metastatic Mucin-Producing Adenocarcinomas.
Rossi G; Cavazza A; Righi L; Sartori G; Bisagni A; Longo L; Pelosi G; Papotti M
Int J Surg Pathol; 2014 Aug; 22(5):401-7. PubMed ID: 24651909
[TBL] [Abstract][Full Text] [Related]
10. [Advanced Pneumonic-type Lung Carcinoma: A Retrospective Study of Clinical-radiological-pathological Characteristics with Survival Analysis in A Single Chinese Hospital].
Liu Y; Li J; Wang S; Chen M; Zhao J; Jiang D; Zhong W; Xu Y; Wang M
Zhongguo Fei Ai Za Zhi; 2019 Jun; 22(6):329-335. PubMed ID: 31196365
[TBL] [Abstract][Full Text] [Related]
11. Multidriver mutation analysis in pulmonary mucinous adenocarcinoma in Taiwan: identification of a rare CD74-NRG1 translocation case.
Gow CH; Wu SG; Chang YL; Shih JY
Med Oncol; 2014 Jul; 31(7):34. PubMed ID: 24913807
[TBL] [Abstract][Full Text] [Related]
12. Mucinous lung adenocarcinoma, particularly referring to EGFR-mutated mucinous adenocarcinoma.
Wakejima R; Inamura K; Ninomiya H; Nagano H; Mun M; Okumura S; Okubo K; Ishikawa Y
Pathol Int; 2020 Feb; 70(2):72-83. PubMed ID: 31859434
[TBL] [Abstract][Full Text] [Related]
13. Solitary Nodular Invasive Mucinous Adenocarcinoma of the Lung: Imaging Diagnosis Using the Morphologic-Metabolic Dissociation Sign.
Cha MJ; Lee KS; Kim TJ; Kim HS; Kim TS; Chung MJ; Kim BT; Kim YS
Korean J Radiol; 2019 Mar; 20(3):513-521. PubMed ID: 30799583
[TBL] [Abstract][Full Text] [Related]
14. Identification of preoperative prediction factors of tumor subtypes for patients with solitary ground-glass opacity pulmonary nodules.
Li M; Wang Y; Chen Y; Zhang Z
J Cardiothorac Surg; 2018 Jan; 13(1):9. PubMed ID: 29343293
[TBL] [Abstract][Full Text] [Related]
15. Role of imaging biomarkers in predicting anaplastic lymphoma kinase-positive lung adenocarcinoma.
Jeong CJ; Lee HY; Han J; Jeong JY; Lee KS; Choi YL; Choi JY
Clin Nucl Med; 2015 Jan; 40(1):e34-9. PubMed ID: 25243942
[TBL] [Abstract][Full Text] [Related]
16. Thyroid transcription factor 1 in pulmonary adenocarcinoma.
Stenhouse G; Fyfe N; King G; Chapman A; Kerr KM
J Clin Pathol; 2004 Apr; 57(4):383-7. PubMed ID: 15047742
[TBL] [Abstract][Full Text] [Related]
17. Genetic features of pulmonary adenocarcinoma presenting with ground-glass nodules: the differences between nodules with and without growth.
Kobayashi Y; Mitsudomi T; Sakao Y; Yatabe Y
Ann Oncol; 2015 Jan; 26(1):156-161. PubMed ID: 25361983
[TBL] [Abstract][Full Text] [Related]
18. Radiological and clinical features of large consolidative-type pulmonary invasive mucinous adenocarcinoma.
Chen J; Qi L; Wang J; Xue L; Xue Q; Jia J; Zhang G; Liu J; Li F; Cui S
Clin Respir J; 2024 Mar; 18(3):e13743. PubMed ID: 38529681
[TBL] [Abstract][Full Text] [Related]
19. Cytomorphological features of ALK-positive lung adenocarcinomas: psammoma bodies and signet ring cells.
Pareja F; Crapanzano JP; Mansukhani MM; Bulman WA; Saqi A
Cancer Cytopathol; 2015 Mar; 123(3):162-70. PubMed ID: 25557162
[TBL] [Abstract][Full Text] [Related]
20. KRAS and NKX2-1 Mutations in Invasive Mucinous Adenocarcinoma of the Lung.
Hwang DH; Sholl LM; Rojas-Rudilla V; Hall DL; Shivdasani P; Garcia EP; MacConaill LE; Vivero M; Hornick JL; Kuo FC; Lindeman NI; Dong F
J Thorac Oncol; 2016 Apr; 11(4):496-503. PubMed ID: 26829311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
